Established in 2018 by seasoned entrepreneurs and investors to nurture promising biotech startups.
Identifying, investing in, and developing the most promising biotech startups in Switzerland and Europe.
Rigorous screening process to identify startups with the most promising technologies and strong teams.
Providing access to state-of-the-art facilities and technologies to accelerate product development.
Leveraging a vast network to connect portfolio companies with strategic partners and investors.
We will continue to provide access to funding, mentorship, drug development support, legal and regulatory guidance, access to industry experts and investors and ofﬁce, laboratory, and manufacturing space.
We aim to expand our biotech portfolio to autoimmune disorders, neurodegenerative diseases, and rare genetic disorders on top of oncology and infectious diseases.
With a strong network of investors and partners, Swiss Rockets AG is well positioned to continue supporting the most promising biotech startups and driving scientiﬁc innovation for improved patient outcomes.